$IGC IGC Pharma Reports First Quarter 2026 Financial Results with CALMA Phase 2 in the final stage, with 80% Enrollment https://www.accessnewswire.com/newsroom/en/biotechnology/igc-pharma-reports-first-quarter-2026-financial-results-with-calma-phase-2-in-the-fin-1168386